Hungary Richter buys intellectual property rights

For drug launch in the United States.

Romanian wholesaler of Hungary's Richter suspended

Hungary's leading pharma company reacts.

ANALYST VIEW - Jefferies lowers target price for Hungary's Richter

To HUF 5,470 from HUF 5,695.

ANALYST VIEW - Hungary's Richter gets 'Hold' rating from Jefferies

After release of Q1 earnings report.

Hungary pharma Richter posts record-low profit over Esmya

Good news about flagship product of Hungary's Richter

Share price on the rise.

Richter drug wins 2017 Innovation Grand Prize in Hungary

Richter awarded for Cariprazine.

Hungary Richter gets good news about product

European Medicines Agency is not a bearer of bad news only.

ANALYST VIEW - Jefferies downgrades Hungary's Richter over Esmya woes

Slashes target price, removes Esmya from model.

Esmya seen causing HUF 42 billion impairment loss for Hungary’s Richter

Negative impact on 2017 profits.

Hungary Richter Q417 after-tax profit undershoots even lowest estimate

Profit of Hungary's leading drugs maker plunges.

Hungary Richter could cause quite a surprise on Monday

Earnings report expected to show profit contraction.

Hungary EcoMin meets local pharma manufacturers

Government to support the sector.

Hungary Richter drug cariprazine passes Phase III bipolar depression trials

Hungary's Richter reacts to Esmya probe

One of key products under EMA investigation.

ANALYST VIEW - Jefferies raises target price for Hungary's Richter

After robust Q3 figures.

Even the rouble cannot ruin the quarter for Hungary's Richter

Profit greatly beats expectations.

Profit of Hungary's Richter seen up despite headwinds

Regardless of rouble trouble.

Hungary Richter buys stake in U.S. company

Signs exclusive distribution agreement with Prima-Temp.

Hungary Richter signs deal with Sweden's Pharmanest

For the commercialisation of novel drug in Europe, Latin America and other markets.